Angela Birnbaum, PhD, FAES, MLS(ASCP)

Dr. Birnbaum is a translational researcher studying the pharmacokinetics of neurological medications using pharmacometrics as a tool, and with an emphasis on neuropharmacology and special populations. Her research focuses on the variability of drug concentrations and response and has included investigations in topics related to the elderly, pregnant women, children, and drug addiction. Her research program includes laboratory measurement of biological specimens and investigations in the stability of drugs in vivo and in vitro; pharmacokinetic and pharmacodynamic studies including investigations of bioavailability, pharmacokinetic, pharmacogenomic, drug interaction, and efficacy studies; and the incorporation of pharmacometric modeling and simulation to answer questions in both intensive and sparse sampling settings. Her research is/has been funded by foundations, The National Institutes of Health, instrumentation companies, and the pharmaceutical industry.

• Medical Cannabis
• Clinical neuropharmacology
• Antiseizure medications
• Special populations including pregnant women, children, and elderly
• Pharmacokinetics/Pharmacodynamics/Pharmacometric analyses
• Analytical drug measurement and stability studies

• Variability in drug exposure and response
• Pharmacokinetics of antiseizure medications in special populations
• Pharmacometrics
• Epilepsy
• Drug addiction

Pubmed